Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic impact of low BMI on outcomes following definitive radiotherapy for esophageal squamous cell carcinoma.

Frontiers in nutrition·2026
Same author

Joint Estimation of Coherent Signal DOA and Polarization Parameters Based on Improved BSBL.

Sensors (Basel, Switzerland)·2026
Same author

Generic generation and manipulation of high-dimensional spin-orbit states in Hilbert space.

Nature communications·2026
Same author

Variation at the ZmCALS5 promoter regulates maize pollen fertility by modulating ZmABI4 binding affinity.

The New phytologist·2026
Same author

Inflammatory Signaling and Emotional Symptoms in Hashimoto's Thyroiditis Beyond Thyroid Function Status.

Neuroendocrinology·2026
Same author

CbLTP67 Negatively Regulates Salt Tolerance by Interaction With CbPAT12 and CbRD19A to Disrupt Salicylic Acid-Mediated Stomatal Closure in Catalpa bungei.

Plant, cell & environment·2026

Related Experiment Videos

Passive Smoking and Thyroid Diseases: Association by Mendelian Randomization Study.

Peijin Li, Ningjing Cai, Zhiguo Ding

    Neuroendocrinology
    |July 2, 2026
    PubMed
    Summary

    Secondhand smoke exposure increases the risk of Graves' disease and thyroid cancer, but may protect against nontoxic single thyroid nodules. Further research is needed to understand these causal links for thyroid disease prevention.

    Related Experiment Videos

    Area of Science:

    • Endocrinology and Environmental Health

    Background:

    • Limited research exists on the causal links between passive smoking and thyroid diseases.
    • Existing studies predominantly focus on active smoking's effects on thyroid health.

    Purpose of the Study:

    • To investigate the potential causal effects of passive smoke exposure on seven common thyroid diseases using a Mendelian randomization approach.
    • To clarify the association between environmental tobacco smoke and thyroid dysfunction.

    Main Methods:

    • A two-sample Mendelian randomization (MR) design was utilized.
    • Data were sourced from the IEU Open GWAS Project.
    • Five MR methods, Cochran's Q test, MR-Egger regression, and leave-one-out analyses were applied to ensure robust and reliable findings.

    Main Results:

    • Passive smoking was found to be a risk factor for Graves' disease (OR = 1.873) and thyroid cancer (OR = 1.515).
    • A protective association was observed between passive smoking and nontoxic single thyroid nodules (OR = 0.670).
    • No significant causal associations were found for hyperthyroidism, hypothyroidism, autoimmune thyroiditis, or subacute thyroiditis.

    Conclusions:

    • Passive smoking is causally linked to increased risk of Graves' disease and thyroid cancer.
    • Passive smoke exposure shows a potential protective effect on nontoxic single thyroid nodules, requiring cautious interpretation and further study.
    • Reducing secondhand smoke exposure may mitigate risks for specific thyroid conditions, highlighting public health implications.